Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

Mauricette Michallet, MD PhD, Romain Buono, PharmD, Mohamad Sobh, PharmD, Solene Poirey, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, MD, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Aude Flechon, MD PhD, Helen Boyle, MD, Franck E Nicolini, MDPhD, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-142355

Published: 2020

Journal Articles

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Romain Buono, Solene Poirey, Isabela Pascu, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Lila Gilis, MD, Franck E Nicolini, MD PhD, Stephane Morisset, BioStat, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD

Blood (2019) 134 (Supplement_1): 5817.

https://doi.org/10.1182/blood-2019-130597

Published: 2019

Journal Articles

Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)

Robert J. Kreitman, MD, Philippe Moreau, Martin Hutchings, MD, Anas Gazzah, MD, Jean-Yves Blay, MD PhD, Zev A. Wainberg, MD, Alexander Stein, MD, Sascha Dietrich, MD, Maja J.A. de Jonge, MD, Wolfgang Willenbacher, MD, Jacques De Greve, MD, Evgeny Arons, PhD, Farhad Ravandi, MD, Fatima Rangwala, Paul Burgess, Bijoyesh Mookerjee, Vivek Subbiah, MD

Blood (2018) 132 (Supplement 1): 391.

https://doi.org/10.1182/blood-2018-99-113135

Published: 2018

Journal Articles

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

Xavier Troussard, MD, Laure Montané, Mourad Tiab, Carine Chaleteix, MD, Isabelle Grulois, Clothilde Lindet, Delphine Legoupil, Frederic Kohser, Diane Pannier, Frederic Maloisel, Pierre Bories, Céline AIT Oukhatar, Natalie Hoog Labouret, Jean-Yves Blay, MD PhD

Blood (2017) 130 (Supplement 1): 156.

https://doi.org/10.1182/blood.V130.Suppl_1.156.156

Published: 2017

Journal Articles

Impact of the Use of Polymerase Chain Reaction for the Diagnosis and Management of Pneumocystis Jirovecii Pneumoniae in a Retrospective Cohort of Patients with Lymphoid Malignancies

Felicite De Charry, MD, Damien Dupont, PharmD, Meja Rabodonirina, MD PhD, Celine Ferlay, Ms, Christine Fuhrmann, MD, Emmanuelle Nicolas-Virelizier, MD, Philippe Rey, MD, Catherine Sebban, MD, Amine Belhabri, MD, Pierre Biron, MD, Jean-Yves Blay, Herve Ghesquieres, MD PhD

Blood (2016) 128 (22): 688.

https://doi.org/10.1182/blood.V128.22.688.688

Published: 2016

Journal Articles

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-Basket Study

Blood (2016) 128 (22): 480.

https://doi.org/10.1182/blood.V128.22.480.480

Published: 2016

Journal Articles

Vemurafenib (VEM) in Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations (V600m): A Cohort of the Histology-Independent VE-Basket Study

Noopur Raje, Ian Chau, David M. Hyman, Vincent Ribrag, Jean-Yves Blay, Josep Tabernero, Maria Elena Elez-Fernandez, Jürgen S. Wolf, Florin Sirzen, Andrew Yee, Jason Faris, Martin Kaiser, Heather Landau, Jean-Marie Michot, Luisa Veronese, Martina Makrutzki, Susan Francis Lasserre, Igor Puzanov, Jose Baselga

Blood (2015) 126 (23): 4263.

https://doi.org/10.1182/blood.V126.23.4263.4263

Published: 2015

Journal Articles

Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution

Herve Ghesquieres, MD PhD, Celine Segura-Ferlay, MS, Gaelle Fossard, MD, Francois Ducray, MD PhD, Violaine Safar, MD, Philippe Rey, MD, Emmanuelle Nicolas-Virelizier, MD, Catherine Sebban, MD, Amine Belhabri, MD, Pierre Biron, MD, Emmanuel Jouanneau, MD PhD, David Meyronnet, MD PhD, Catherine Chassagne-Clement, MD, Jerome Honnorat, MD PhD, Jean-Yves Blay, MD PhD

Blood (2015) 126 (23): 1544.

https://doi.org/10.1182/blood.V126.23.1544.1544

Published: 2015

Journal Articles

The Efficacy of Vemurafenib in Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Preliminary Results from VE-Basket Study

David M. Hyman, MD, Eli Diamond, Vivek Subbiah, MD, Jean-Yves Blay, MD PhD, A. Craig Lockhart, Omar Abdel-Wahab, MD, Florin Sirzen, Maria Luisa Veronese, MD, Susan Frances Laserre, Elena Elez, Jose Baselga, MD PhD

Blood (2014) 124 (21): 635.

https://doi.org/10.1182/blood.V124.21.635.635

Published: 2014

Journal Articles

Updated Results Confirm Favorable Outcome of Immunocompetent Patients with Primary CNS Lymphoma Treated By C5R Protocol in Combination with Intravenous Rituximab and Intrathecal Liposomal Cytarabine: A Multicentric Prospective Phase 2 Study of the Lymphoma Study Association (LYSA)

Herve Ghesquieres, MD PhD, Herve Tilly, MD PhD, Anne Sonet, MD, Jehan Dupuis, MD, Alexia Schwartzmann, Emmanuelle Nicolas-Virelizier, MD, Marc Andre, MD PhD, Fabienne Trullemans, MD, Emmanuel Fleck, MD, Sami Boussetta, Franck Morschhauser, MD PhD, Jean-Yves Blay, MD PhD

Blood (2014) 124 (21): 3060.

https://doi.org/10.1182/blood.V124.21.3060.3060

Published: 2014

Journal Articles

Utility Of Post Therapy Brain Surveillance Imaging In The Detection Of Primary CNS Lymphoma (PCNSL) Relapse

Gaelle Fossard, MD, Emmanuelle Nicolas-Virelizier, MD, Philippe Rey, MD, Francois Ducray, MD, Emmanuel Jouanneau, MD, PhD, Pierre Faurie, MD, Amine Belhabri, MD, Marie Pierre Sunyach, MD, Catherine Chassagne-Clement, MD, Philippe Thiesse, MD, Catherine Sebban, MD, Pierre Biron, MD, Jean-Yves Blay, MD, PhD, Herve Ghesquieres, MD, PhD

Blood (2013) 122 (21): 933.

https://doi.org/10.1182/blood.V122.21.933.933

Published: 2013

Journal Articles

A Multicentric Prospective Phase 2 Study of Intravenous Rituximab and Intrathecal Liposomal Cytarabine in Combination with C5R Protocol Followed by Brain Radiotherapy for Immunocompetent Patients with Primary CNS Lymphoma: A Lymphoma Study Association (LYSA) Trial

Herve Ghesquieres, MD, PhD, Herve Tilly, MD, Anne Sonet, MD, Jehan Dupuis, MD, Alexia Schwartzmann, Emmanuelle Nicolas-Virelizier, MD, Marc Andre, MD, Fabienne Trullemans, MD, Emmanuel Fleck, MD, Sami Boussetta, Franck Morschhauser, MD, PhD, Jean-Yves Blay, MD, PhD

Blood (2012) 120 (21): 796.

https://doi.org/10.1182/blood.V120.21.796.796

Published: 2012

Journal Articles

First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis

Blood (2012) 120 (21): 3655.

https://doi.org/10.1182/blood.V120.21.3655.3655

Published: 2012

Journal Articles

Prognostic Value of 18F-FDG Positron Emission Tomography Used for Assessment of the First Line Therapy in 410 Diffuse Large B-Cell Lymphoma Patients: A Daily Practice Evaluation Before and After the Prescription of This Metabolic Imaging Technique,

Herve Ghesquieres, MD, PhD, Céline Ferlay, Emilie Lavergne, Emmanuelle Nicolas Virelizier, MD, Izabela-Irina Domnisoru, MD, Philippe Rey, MD, Thérèse Gargi, Sylvie Chabaud, MD, Catherine Chassagne-Clément, MD, Bertrand Favier, PhD, Pierre Biron, MD, Thomas Mognetti, MD, Vanina Isnardi, MD, Catherine Sebban, MD, Jean-Yves Blay, MD, PhD, Sébastien Cimarelli, MD

Blood (2011) 118 (21): 3686.

https://doi.org/10.1182/blood.V118.21.3686.3686

Published: 2011

Journal Articles

Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up,

Emmanuelle Nicolas Virelizier, MD, Celine Segura-Ferlay, Izabela-Irina Domnisoru, MD, Philippe Rey, MD, Thérèse Gargi, Catherine Chassagne-Clément, MD, Bertrand Favier, PhD, Pierre Biron, MD, Amine Belhabri, MD, Catherine Sebban, MD, Jean-Yves Blay, MD, PhD, Herve Ghesquieres, MD, PhD

Blood (2011) 118 (21): 3698.

https://doi.org/10.1182/blood.V118.21.3698.3698

Published: 2011

Journal Articles

Usefulness of Positron Emission Tomography Using 18F-FDG Performed At Diagnosis and During Initial Chemotherapy for Imaging Primary Central Nervous System Lymphoma: A 24 Immunocompetent patient's Study.

Herve Ghesquieres, MD, PhD, Céline Ferlay, Bertrand Richioud, MD, Vanina Isnardi, MD, Emmanuelle Nicolas-Virlizier, MD, Izabela-Irina Domnisoru, MD, Philippe Rey, MD, François Ducray, MD, Jérome Honnorat, MD, PhD, Emmanuel Jouanneau, MD, PhD, Marie Pierre Sunyach, MD, Pierre Biron, MD, Catherine Sebban, MD, Jean-Yves Blay, MD, PhD, Sébastien Cimarelli, MD

Blood (2011) 118 (21): 1597.

https://doi.org/10.1182/blood.V118.21.1597.1597

Published: 2011

Journal Articles

CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues

Vanja Sisirak, Nelly Vey, Béatrice Vanbervliet, Thomas Duhen, Isabelle Puisieux, Bernhard Homey, Edward P. Bowman, Giorgio Trinchieri, Bertrand Dubois, Dominique Kaiserlian, Sergio A. Lira, Alain Puisieux, Jean-Yves Blay, Christophe Caux, Nathalie Bendriss-Vermare

Blood (2011) 118 (19): 5130–5140.

https://doi.org/10.1182/blood-2010-07-295626

Published: 2011

Includes: Supplemental data

Journal Articles

Prognostic Impact of Elevated Serum Ferritin at Diagnosis of Diffuse Large B-Cell Lymphoma Treated In the Rituximab Era

Herve Ghesquieres, MD, Ferlay Céline, Lachenal Florence, MD, Nicolas-Virlizier Emmanuelle, MD, Domnisoru Izabella-Irina, MD, Rey Philippe, MD, Gargi Thérèse, Chassagne-Clement Catherine, MD, Favier Bertrand, PhD, Biron Pierre, MD, Sebban Catherine, MD, Jean-Yves Blay, MD, PhD

Blood (2010) 116 (21): 5080.

https://doi.org/10.1182/blood.V116.21.5080.5080

Published: 2010

Journal Articles

Use of Chemotherapy and Immunotherapy the Last Four Weeks of life in Patients with Lymphoma in An Anticancer Center with Focus On the Impact of Time Period (1998-2002 and 2003-2008).

Catherine Sebban, MD, Hervé Ghesquieres, MD, Corinne Carcel, MD, Philippe Rey, MD, Therese Gargi, Yves Devaux, MD, Frederic Gomez, MD, Giselle Chvetzoff, MD, Pierre Biron, MD, David Coeffic, MD, Jean-Yves Blay, MD, PhD, Bertrand Favier, PhD

Blood (2009) 114 (22): 4537.

https://doi.org/10.1182/blood.V114.22.4537.4537

Published: 2009

Journal Articles

Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte.

Blood (2009) 114 (22): 101.

https://doi.org/10.1182/blood.V114.22.101.101

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

Impact of the Use of Polymerase Chain Reaction for the Diagnosis and Management of Pneumocystis Jirovecii Pneumoniae in a Retrospective Cohort of Patients with Lymphoid Malignancies

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-Basket Study

Vemurafenib (VEM) in Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations (V600m): A Cohort of the Histology-Independent VE-Basket Study

Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution

The Efficacy of Vemurafenib in Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Preliminary Results from VE-Basket Study

Updated Results Confirm Favorable Outcome of Immunocompetent Patients with Primary CNS Lymphoma Treated By C5R Protocol in Combination with Intravenous Rituximab and Intrathecal Liposomal Cytarabine: A Multicentric Prospective Phase 2 Study of the Lymphoma Study Association (LYSA)

Utility Of Post Therapy Brain Surveillance Imaging In The Detection Of Primary CNS Lymphoma (PCNSL) Relapse

A Multicentric Prospective Phase 2 Study of Intravenous Rituximab and Intrathecal Liposomal Cytarabine in Combination with C5R Protocol Followed by Brain Radiotherapy for Immunocompetent Patients with Primary CNS Lymphoma: A Lymphoma Study Association (LYSA) Trial

First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis

Prognostic Value of 18F-FDG Positron Emission Tomography Used for Assessment of the First Line Therapy in 410 Diffuse Large B-Cell Lymphoma Patients: A Daily Practice Evaluation Before and After the Prescription of This Metabolic Imaging Technique,

Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up,

Usefulness of Positron Emission Tomography Using 18F-FDG Performed At Diagnosis and During Initial Chemotherapy for Imaging Primary Central Nervous System Lymphoma: A 24 Immunocompetent patient's Study.

CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues

Prognostic Impact of Elevated Serum Ferritin at Diagnosis of Diffuse Large B-Cell Lymphoma Treated In the Rituximab Era

Use of Chemotherapy and Immunotherapy the Last Four Weeks of life in Patients with Lymphoma in An Anticancer Center with Focus On the Impact of Time Period (1998-2002 and 2003-2008).

Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only